Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000091

Chief Commercial Officer gave up 1,485 shares (to pay taxes)

  • Chief Commercial Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Poddar Richa · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-15 Exercise or conversion : show line 1 in the form +5,000 9,993 D
2022-10-17 Shares withheld for taxes : show line 2 in the form −1,485 $27.48 $40,808 8,508 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-15 Exercise or conversion : show line 3 in the form Restricted stock units −5,000 0 D
Loading xslF345X03/wf-form4_166612418262958.xml…